Hologic jumps after report of rejected $16 bln TPG-Blackstone buyout offer

Shares of medical device maker Hologic HOLX.O rise 14% to $61.85 in afternoon trading

HOLX has rejected a $16 billion non-binding offer from private equity firms TPG TPG.O and Blackstone BX.N to take the company private, the Financial Times reports, citing people familiar with the matter

The deal valued HOLX's shares at $70 to $72, the report added, around 30% premium to its last closing price of $54.28

Despite rejecting the offer, there is still a chance that deal talks could be revived in the future - FT

Including session's moves, stock down 6.6% YTD